Assistant Professor
University of British Columbia
Dr. Ricky Turgeon received his BSc(Pharm) in 2012 from the Dalhousie University College of Pharmacy, his ACPR from the Lower Mainland Pharmacy Services Residency Program in 2013, and his PharmD in the Faculty of Pharmaceutical Sciences at UBC in 2015. He then completed a two-year post-doctoral fellowship in cardiovascular pharmacotherapy at the University of Alberta Division of Cardiology in 2018. Currently, Dr. Turgeon is assistant professor at the UBC Faculty of Pharmaceutical Sciences, and clinical pharmacy specialist at the PHARM-HF clinic, a pharmacist-led heart failure medication optimization clinic, at St. Paul's Hospital in Vancouver.
Dr. Turgeon’s research focuses on integrating evidence and shared decision-making into clinical practice to optimize the care of people living with cardiovascular disease. His clinical focus is in optimal use of heart failure pharmacotherapy, medication safety in cardiovascular disease, and medications to reduce cardiovascular risk (e.g., antithrombotic, lipid-lowering, and antihypertensive medications).
His group uses various methods, including observational designs (cohort or case-control study using administrative data and clinical registries), clinical prediction model development and validation, pragmatic randomized controlled trials, and evidence syntheses (systematic reviews with or without meta-analyses, scoping reviews, and modeling studies) to address important clinical questions in cardiovascular pharmacotherapy.
Disclosure(s): No financial relationships to disclose
240 - CCPN SPOTLIGHT: JOURNEY THROUGH THE CARDIOVASCULAR DISEASE CONTINUUM
Friday, October 25, 2024
2:00 PM – 3:00 PM PT